Microcrystal electron diffraction

XtalPi Unveils XtalGazer: A Comprehensive AI-Driven Polymorph Selection Platform

Retrieved on: 
Giovedì, Marzo 28, 2024
Ecosystem, API, Bias, Crystallization, Robotics, Research, Microcrystal electron diffraction, Artificial intelligence, Inc., Drug development

This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approaches.

Key Points: 
  • This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approaches.
  • XtalGazer provides a total solution for delivering high-quality polymorph screening and selection methods to expedite drug development and mitigate risks.
  • From crystal structure prediction platforms being one of the first products to launch at XtalPi, to today's comprehensive polymorph selection platform, XtalPi will keep fulfilling its promise to solving challenging problems in this space.
  • XtalPi will continue to deliver faster, more accurate, and more comprehensive approaches to building an ecosystem for the R&D process in solid-state, pre-formulation and crystallization.

XtalPi Unveils XtalGazer: A Comprehensive AI-Driven Polymorph Selection Platform

Retrieved on: 
Giovedì, Marzo 28, 2024
Ecosystem, API, Bias, Crystallization, Robotics, Research, Microcrystal electron diffraction, Artificial intelligence, Inc., Drug development

This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approaches.

Key Points: 
  • This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approaches.
  • XtalGazer provides a total solution for delivering high-quality polymorph screening and selection methods to expedite drug development and mitigate risks.
  • From crystal structure prediction platforms being one of the first products to launch at XtalPi, to today's comprehensive polymorph selection platform, XtalPi will keep fulfilling its promise to solving challenging problems in this space.
  • XtalPi will continue to deliver faster, more accurate, and more comprehensive approaches to building an ecosystem for the R&D process in solid-state, pre-formulation and crystallization.

Thermo Fisher Scientific Announces New Cryo-TEM with Expansive Automation Features to Help Accelerate Drug Discovery Research

Retrieved on: 
Mercoledì, Ottobre 5, 2022
Software, Research, Hardware, Pharmaceutical, Biometrics, Technology, Medical Devices, Infectious Diseases, Health Technology, Science, Biotechnology, Health, Other Science, Drug design, Thermo Fisher Scientific, Glacio, Acquisition, Transmission electron cryomicroscopy, Research, Multimedia, Microcrystal electron diffraction, Mindful Scientific Inc., Cancer, Automation, Microscope

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific Glacios 2 Cryo-Transmission Electron Microscope (Cryo-TEM), a powerful microscope with new automation and high-resolution imaging capabilities designed to help cryo-electron microscopy (cryo-EM) researchers of varying experience levels accelerate structure-based drug discovery.

Key Points: 
  • Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific Glacios 2 Cryo-Transmission Electron Microscope (Cryo-TEM), a powerful microscope with new automation and high-resolution imaging capabilities designed to help cryo-electron microscopy (cryo-EM) researchers of varying experience levels accelerate structure-based drug discovery.
  • This advanced, fast and cost-efficient method for drug design may enable customers to accelerate the pace of research for debilitating disorders like Alzheimers, Parkinsons, and Huntingtons diseases, as well as research for cancer and gene mutations.
  • This next generation solution can generate
  • Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.

Winners of the 2022 Blavatnik National Awards for Young Scientists announced

Retrieved on: 
Mercoledì, Giugno 29, 2022
Artificial intelligence, Social, Life, CEO, Research, Engineering, American Museum, Blavatnik Awards for Young Scientists, Stroke, Harvard University, Multimedia, Council, ALS, Natural history, New York Academy of Sciences, United Kingdom, Risk, Investment, STEM, Microcrystal electron diffraction, New, University, American, Access Industries, Nervous system, Health, Extrapyramidal system, Academy, Lists of diseases, Human, Medicine, NEW, Chemistry, Journal, UCLA, Pharmaceutical industry, Civil engineering, California Institute of Technology, Science

NEW YORK, June 29, 2022 /PRNewswire/ -- The Blavatnik Family Foundation and the New York Academy of Sciences announced today a neurobiologist, a synthetic chemist and a mechanical engineer as the laureates of the 2022 Blavatnik National Awards for Young Scientists.

Key Points: 
  • The 2022 Blavatnik National Awards competition received 309 nominees from 150 research institutions across 38 states.
  • The Blavatnik National Awards for Young Scientists will celebrate the 2022 laureates and finalists in a ceremony on Sept. 19 at the American Museum of Natural History in New York.
  • The Blavatnik National Awards for Young Scientists, established by the Blavatnik Family Foundation in 2007 and independently administered by the New York Academy of Sciences, began by identifying outstanding regional scientific talent in New York, New Jersey and Connecticut.
  • The Blavatnik National Awards were first awarded in 2014 and expanded in 2017 to honor faculty-rank scientists in the UK and Israel.

First-of-its-kind Commercial MicroED Solution Helps Researchers Quickly Resolve Organic and Inorganic Molecular Structures at Atomic Resolution

Retrieved on: 
Giovedì, Aprile 25, 2019
Physical sciences, Natural sciences, Physics, Electron microscopy, Microcrystal electron diffraction, MicroScope, Transmission electron microscopy, Electron microscope, X-ray crystallography, Diffraction, Electron

The new Thermo Scientific MicroED solution, compatible with Thermo Scientific transmission electron microscopes (TEMs), enables scientists to perform analyses faster and with greater reproducibility than non-integrated MicroED offerings.

Key Points: 
  • The new Thermo Scientific MicroED solution, compatible with Thermo Scientific transmission electron microscopes (TEMs), enables scientists to perform analyses faster and with greater reproducibility than non-integrated MicroED offerings.
  • The solution includes the CETA-D detector, optimized for diffraction imaging, and specialized MicroED software that automates the entire data acquisition process.
  • "This solution allows researchers to accelerate innovation in key areas such as drug discovery and green energy advancements."
  • MicroED uses electrons to analyze crystallized protein samples previously too small and sensitive to observe with traditional x-ray diffraction methods.